Moderately bullish activity in Pfizer (PFE), with shares up 32c, or 1.3%, near $25.39. Options volume relatively light with 20k contracts traded and calls leading puts for a put/call ratio of 0.23, compared to a typical level near 0.5. Implied volatility (IV30) is higher by 0.1 points near 18.15,in the lowest 10% of observations over the past year, suggesting an expected daily move of $0.29. Put-call skew steepened, indicating increased demand for downside protection.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PFE:
- Pfizer Canada, BioNTech get Health Canada approval for COVID variant vaccine
- Mixed options sentiment in Pfizer with shareslittle changed
- This Activist Investor Ramped Up Salesforce (NYSE:CRM) Stake by 50% in Q2
- Pfizer’s (PFE) Sickle Cell Drug Fails to Meet Its Main Goal
- Trump Weekly: Trump weighs stake in Intel, candidates for Fed Chair